S-Space

Browse

Subject

Showing results 1 to 3 of 3

Issue Date	Title / Author(s) / Citation	File
2014-04	Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling Lee, Jin-Ku; Joo, Kyeung Min; Lee, Jeongwu; Yoon, Yeup; Nam, Do-Hyun OncoTargets and Therapy, Vol.7, pp.1933-1944	DOI
2014-08	Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog International Journal of Clinical Oncology, Vol.19 No.4, pp.594-600	DOI
2019-10	The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab Shin, Jung Won; Kim, Soohyun; Ha, Suji; Choi, Byungsan; Kim, Seongyeong; Im, Seock-Ah; Yoon, Tae-Young; Chung, Junho Biomolecules, Vol.9 No.10, p. 629	DOI